Neurotec Pharma SL ' Product Pipeline Review ' 2012

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Neurotec Pharma SL ' Product Pipeline Review ' 2012
Published on December 2012

Report Summary


Summary

Global Market Direct's pharmaceuticals report, "Neurotec Pharma SL - Product Pipeline Review - 2012" provides data on the
Neurotec Pharma SL's research and development focus. The report includes information on current developmental pipeline, complete
with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Neurotec Pharma SL's
corporate website, SEC filings, investor presentations and featured press releases, both from Neurotec Pharma SL and
industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Neurotec Pharma SL - Brief Neurotec Pharma SL overview including business description, key information and facts, and its
locations and subsidiaries.
- Review of current pipeline of Neurotec Pharma SL human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities,
across the globe.
- Product profiles for late stage and clinical stage products of Neurotec Pharma SL with complete description of the product's
developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Neurotec Pharma SL's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Neurotec Pharma SL's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Neurotec Pharma SL in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Neurotec Pharma SL's R&D portfolio and develop key strategic initiatives to
reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Neurotec Pharma SL.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Neurotec Pharma SL and identify potential opportunities in those areas.

Neurotec Pharma SL ' Product Pipeline Review ' 2012 (From Slideshare) Page 1/5


Table of Content

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Neurotec Pharma SL Snapshot 4
Neurotec Pharma SL Overview 4
Key Information 4
Key Facts 4
Neurotec Pharma SL ' Research and Development Overview 5
Key Therapeutic Areas 5
Neurotec Pharma SL ' Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products ' Monotherapy 8
Neurotec Pharma SL ' Pipeline Products Glance 9
Neurotec Pharma SL Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Neurotec Pharma SL ' Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Neurotec Pharma SL ' Drug Profiles 11
NT-CC-017 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
NT-FV-007 12
R&D Progress 12
NT-KC-005 13
R&D Progress 13
NT-KO-003 14
R&D Progress 14
NT-KO-009 16
R&D Progress 16
NT-KO-012 17
R&D Progress 17



Neurotec Pharma SL ' Pipeline Products by Route of Administration 18
Neurotec Pharma SL ' Pipeline Products By Mechanism of Action 19
Neurotec Pharma SL ' Locations And Subsidiaries 20
Head Office 20
Financial Deals Landscape 21
Neurotec Pharma SL, Deals Summary 21
Neurotec Pharma SL, Pharmaceuticals & Healthcare, Deal Details 22
Venture Financing 22
Neurotec Pharma Secures Venture Financing 22
Partnerships 23
ADMEcell And Applied Research using OMIC Sciences Enters Into Co-Development Agreement With Neurotec Pharma 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25

List of Tables

Neurotec Pharma SL, Key Information 4
Neurotec Pharma SL, Key Facts 4
Neurotec Pharma SL ' Pipeline by Indication, 2012 6
Neurotec Pharma SL ' Pipeline by Stage of Development, 2012 7
Neurotec Pharma SL ' Monotherapy Products in Pipeline, 2012 8
Neurotec Pharma SL ' Phase II, 2012 9
Neurotec Pharma SL ' Pre-Clinical, 2012 10
Neurotec Pharma SL ' Pipeline By Route of Administration, 2012 18
Neurotec Pharma SL ' Pipeline Products By Mechanism of Action, 2012 19
Neurotec Pharma SL, Deals Summary 21
Neurotec Pharma Secures Venture Financing 22
ADMEcell And Applied Research using OMIC Sciences Enters Into Co-Development Agreement With Neurotec Pharma 23

List of Figures

Neurotec Pharma SL ' Pipeline by Indication, 2012 6
Neurotec Pharma SL ' Pipeline by Stage of Development, 2012 7
Neurotec Pharma SL ' Monotherapy Products in Pipeline, 2012 8


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 1 500.00 Quantity: _____

Site License--USD 3 000.00 Quantity: _____

Corporate License--USD 4 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Neurotec Pharma SL ' Product Pipeline Review ' 2012

Recommandé

Recommandé

Contenu connexe

En vedette

En vedette (11)

Plus de ReportLinker.com

Plus de ReportLinker.com (20)

Neurotec Pharma SL ' Product Pipeline Review ' 2012